Fasting for Myocardial Infarction
(BACON-RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether fasting is necessary before urgent heart procedures, specifically cardiac catheterizations. Researchers aim to determine if eating and drinking beforehand increases patient comfort without raising risks such as vomiting or breathing issues. Participants will join one of two groups: one that fasts and one that does not. Individuals experiencing worsening chest pain or who have had a mild heart attack and are scheduled for a non-high risk heart procedure might be eligible to join.
As an unphased trial, this study provides an opportunity to contribute to important research that could enhance patient comfort during heart procedures.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for patients undergoing cardiac catheterization?
Research has shown that fasting can be safe for individuals with stable heart conditions. Some studies suggest that fasting might improve heart health by lowering blood pressure and cholesterol levels. However, other research highlights certain risks. For instance, consuming all meals within a short time frame, such as 8 hours a day, has been linked to a higher risk of heart-related deaths. Individuals should consider these mixed findings when contemplating fasting before medical procedures. Weighing the potential benefits and risks is crucial, especially for those with heart issues.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring how fasting before cardiac catheterization might affect heart attack outcomes. Unlike standard treatments for myocardial infarction, which often rely on medications like antiplatelets and beta-blockers, this trial is investigating a simple change in dietary protocol. Fasting could potentially enhance procedural outcomes or recovery by reducing complications during the procedure. Researchers hope to find out if this dietary adjustment can offer a straightforward, non-invasive way to improve heart attack treatment.
What evidence suggests that fasting or non-fasting before cardiac catheterization could be effective for improving patient comfort and safety?
Research has shown that intermittent fasting might help lower risk factors for heart disease. Some studies suggest that fasting does not increase the risk of heart attacks and might even reduce it. However, strong evidence is lacking that fasting directly improves outcomes in urgent heart procedures like cardiac catheterizations. This trial will compare two groups: one will follow standard pre-procedural fasting guidelines, and the other will have no dietary restrictions before their cardiac catheterization. The researchers aim to determine if patients can eat and drink before such procedures without increasing risks like vomiting or breathing problems. The goal is to balance patient comfort and safety with or without fasting.678910
Who Is on the Research Team?
Samip Vasaiwala, MD
Principal Investigator
USF Department of Internal Medicine; Division of Cardiovascular Sciences
Are You a Good Fit for This Trial?
This trial is for patients with stable angina or ischemic heart disease who are undergoing urgent inpatient cardiac catheterizations. Participants should not have any conditions that would make fasting unsafe or influence the study's results.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cardiac catheterization with either standard fasting or no fasting protocol
Follow-up
Participants are monitored for safety outcomes such as aspiration pneumonia, sedation use, and 30-day mortality
What Are the Treatments Tested in This Trial?
Interventions
- Fasting
- Non-Fasting
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor